Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
60
NCT00852228
Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy
Phase: Phase 2
Role: Collaborator
Start: Jul 31, 2008
Completion: Dec 31, 2015